Vanderbilt University
July 2005
Thursday, July 21, 2005
Friday, July 22, 2005
8:30 - 8:50 am
|
|
Welcome and Introductions |
8:50 - 9:20 am
|
|
Pharmacologists as Dinomammals: The Changing Face of Pharmacology
Robert Gould, PhD, Senior Vice President, Merck Pharmaceuticals, Boston, MA |
9:20 - 9:50 am |
|
What the Pharmaceutical Industry Requires for Success
Marlene Cohen, PhD, Distinguished Lilly Fellow (retired) , Eli Lilly and Company,Adjunct Professor of Pharmacology, Indiana University School of Medicine, and Vice President, Creative Pharmacology Solutions LLC, Carmel IN |
9:50 - 10:15 am |
|
The World of West Coast Biotechs: Needs and Opportunities
Franz F. Hefti, PhD, Executive Vice President, Drug Development, Rinat Neuroscience, Palo Alto, CA |
10:15 - 10:35 am |
|
Break |
10:35 - 11:00 am |
|
An Academic Perspective to 'Marketing' Pharmacology
Barbara Beckman, PhD, Professor of Pharmacology and Assistant Dean of Admissions, Tulane Medical School, New Orleans, LA |
11:00 - 11:25 am |
|
Interdisciplinary Umbrella Programs...Perceptions on the Vanderbilt IGP After 14 Years
Roger Chalkley, DPhil, Senior Associate Dean, Biomedical Research Education and Training, Vanderbilt University, Nashville, TN |
11:25 - 11:55 am |
|
Representing the Underrepresented
Lou DeFelice, PhD, Professor of Pharmacology and Neuroscience, Director of the Vanderbilt Bridges Program, Vanderbilt University, Nashville, TN |
|
|
Lunch break |
1:15 - 1:35 pm |
|
Task Force on Learning Objectives for Graduate Students in Pharmacology
J.R. Haywood, PhD, Professor and Chairperson, Pharmacology and Toxicology, Michigan State University, East Lansing, MI |
1:35 - 3:00 pm
|
|
Curriculum Presentations
Richard Robinson , PhD, Columbia University
Lonny Levin , PhD, Cornell University
David Riddick , PhD, University of Toronto
Lee Graves , PhD, University of North Carolina at Chapel Hill
Robert Speth , PhD, University of Mississippi
Brian Knoll, PhD, University of Houston
Edward Morgan , PhD, Emory University
|
| 3:15 - 5:30 pm |
|
Breakout Sessions |
Session 1
3:15-4:00 |
Undergraduate Programs
(Discussion Leader:
Barbara Beckman )
Hamm
|
Umbrella Programs
(Discussion Leaders:
R. Chalkley and J. Barnett)
Eltom
|
Master's Degrees
(Discussion Leaders:
J.R. Haywood and J. Lucot )
Sawyer
|
Session 2
4:00-4:45 |
Curriculum Issues
(Discussion Leader:
R. Robinson)
Sawyer
|
Minority Issues
(Discussion Leader:
L. DeFelice)
Hamm
|
NIH
(Discussion Leeaders:
P. Preusch and A. Zajicek)
Barnett
|
Session 3
4:45-5:30 |
Curriculum Issues
(Discussion Leader:
Y. Tu)
Barnett
|
Umbrella Programs
(Discussion Leader:
R. Chalkley)
Beckman
|
NIH
(Discussion Leaders:
P. Preusch and A. Zajicek)
Eltom
|
| 5:30 - 7:00 pm |
|
Science Poster Session & Reception - Pharmacology
Graduate Students from
Vanderbilt and Meharry |
Saturday, July 23, 2005
| 9:00 - 9:30 am |
|
Business Meeting
Joey Barnett, PhD, Vice-Chair in Pharmacology, Director of Graduate Studies in Pharmacology, Associate Professor of Pharmacology, Medicine, and Microbiology and Immunology, Vanderbilt University, Nashville, TN |
| 9:30 - 10:10 am |
|
Pharmacological Sciences Training Grants - Progress Report
Peter Preusch, PhD, NIGMS Training Grant Program Director, National Institutes of Health, Bethesda, MD |
| 10:10 - 10:50 am |
|
Pediatric Clinical Pharmacology: What's New at NIH
Anne Zajicek, MD/PharmD, Pediatric Medical Officer, National Institues of Health, Bethesda, MD |
During this historic meeting, we asked participants to complete a
questionnaire/survey of their Pharmacology program. Dr. Barnett presented
some of the preliminary data during the Business Meeting (see link, above).
For the blind final data analysis, click here. For comments on the challenges and opportunities faced by various institutions, click here.
If you prefer the unblinded data, please contact Dr. Barnett at joey.barnett@vanderbilt.edu and he will be happy to accommodate your request.
To access a PowerPoint summary of the data, click here.
List of Participants